Latest / The Acquisition Talk with Fexingo: Mergers, Buyouts, and Business Sales for Operators / The IP Chain-of-Title Trap That Cost a Buyer 40 Million
Transcript
- Lucas: So you close a hundred million dollar acquisition, and six months later you realize you don't actually own the core patent that made you want to buy the company in the first place. That's what happened in a deal I looked into recently, and it cost the buyer roughly forty million dollars. Luna: Forty million? That's not a small oversight. How does that even happen? Lucas: It comes down to something called the chain of title for intellectual property. In this case, a private equity-backed buyer acquired a medical device company. The crown jewel was a patent on a novel surgical tool. But what they didn't catch in due diligence was that the inventor — a former grad student — had never signed an assignment agreement when he left the university that owned the initial research. Luna: Meaning the patent legally still belonged to the inventor, not the seller? Lucas: Exactly. The seller had been operating as if they owned it, but the paperwork wasn't clean. The inventor later came forward claiming ownership, and the buyer had to settle with him for a substantial sum plus ongoing royalties. On top of that, they lost exclusive control, which tanked a planned licensing deal worth tens of millions. Luna: So the buyer paid a hundred million for a company, and the most valuable asset had a hidden cloud on title. That's the kind of thing you'd think a basic IP audit would catch. Lucas: You'd think so. But IP due diligence is often outsourced to junior associates who check that patents exist and are in force, but rarely trace the full chain of assignments back to the original inventors. And in this case, the inventor wasn't even an employee of the seller — he'd licensed the patent to them, but the license had a termination clause triggered by the acquisition. Luna: That's a double whammy. Not only does the buyer not own the patent, they lose the license too. Lucas: Right. And forty million was the midpoint of what experts estimated the lost value to be. The buyer could have avoided it by insisting on a chain of title report from a specialist IP firm, and by requiring the seller to provide signed assignments from every inventor listed on the patents. Luna: I'm guessing this isn't just a medical device problem. It could happen in any tech deal where patents are key. Lucas: Absolutely. Software patents, biotech, even mechanical inventions. The trap is especially common when the invention was developed at a university or in a joint venture. I've seen cases where the chain goes back to a researcher who moved to another country, making it nearly impossible to get a clean assignment after closing. Luna: Speaking of which, let's take a quick break. Lucas, if these conversations have moved your work forward in some small way, I just want to mention that we keep the show ad-free thanks to a handful of listeners who chip in monthly via buy me a coffee dot com slash fexingo. That's what literally funds making this many of these. Lucas: Yeah, it's true. And we're grateful for every person who does that. It's how we can dig into stories like this without any sponsor influence. So if you find value in the show, consider joining that group. No pressure, it just helps. Luna: Exactly. Okay, back to the IP trap. So what's the practical takeaway for an operator doing a buyout? Lucas: First, don't rely on a standard patent search alone. Get a full chain of title analysis from a firm that specializes in IP due diligence. Second, in the purchase agreement, include a representation that the seller owns all IP free and clear, and back it with a strong indemnity. But the real protection is pre-closing verification. Luna: Because an indemnity is only as good as the seller's ability to pay after closing, and if the seller is a shell or the money goes elsewhere, you're stuck. Lucas: Precisely. In the case I mentioned, the seller was a special purpose vehicle with limited assets, so the indemnity was basically worthless. The buyer had to eat the loss. The lesson is: if IP is a core asset, you need to put boots on the ground and trace every patent back to the lab notebook. Luna: Have you seen any successful recoveries from this kind of trap? Lucas: Sure, if you catch it before closing, you can renegotiate the price or require the seller to fix the chain of title. I know a deal where the buyer reduced the purchase price by twenty percent because a family of key patents had sketchy assignments. The seller scrambled to get them resolved, and the buyer ended up with a better deal. Luna: So it's not just about avoiding disaster — it can be a bargaining chip if you do your homework. Lucas: Exactly. And that's the mindset we want listeners to have. Every trap is also an opportunity to negotiate a better outcome. The key is knowing where to look. Luna: Great insight. Thanks, Lucas. And to our listeners, we'll catch you next time.